The controversial preservative thimerosal will be stripped from all influenza vaccines distributed in the United States.

Children hospitalized with RSV showed higher risk for ICU admission, IMV, and supplemental oxygen than children hospitalized with COVID-19 or influenza.

IV induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately to severely active Crohn disease.

Janus kinase (JAK) inhibitors are associated with decreased mortality and fewer serious adverse events among adults hospitalized with COVID-19.

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.

Pemivibart was well tolerated and prophylactic against COVID-19 infection among adult patients with significant immunocompromising conditions.